title: Late relapse after autologous BMT.
authors.forename: P
authors.initials: P
authors.lastname: Salutari
authors.forename: G
authors.initials: G
authors.lastname: Micciulli
authors.forename: P
authors.initials: P
authors.lastname: Chiusolo
authors.forename: M
authors.initials: M
authors.lastname: Tommasi
authors.forename: A
authors.initials: A
authors.lastname: Di Mario
authors.forename: S
authors.initials: S
authors.lastname: Sica
authors.forename: G
authors.initials: G
authors.lastname: Leone
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage; D015479:Leukemia, Myelomonocytic, Acute / Q000188:drug therapy / Q000628:therapy*; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage; D009364:Neoplasm Recurrence, Local; D013997:Time Factors
chemical_list: D003561:Cytarabine; D005047:Etoposide; D003520:Cyclophosphamide; D008942:Mitoxantrone; D002066:Busulfan; D015255:Idarubicin